Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH – Subprotocol J)

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH – Subprotocol J)
Conditions: Malignant Solid Neoplasm

Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Echocardiography; Biological: Pertuzumab; Procedure: Radiologic Examination; Biological: Trastuzumab

Sponsors: National Cancer Institute (NCI)

Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 19, 2023Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments